Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EC sets new deadline for Zentiva competition review

This article was originally published in Scrip

Executive Summary

The European Commissionhas moved the deadline for the completion of its competition review of Sanofi-Aventis's proposal to buy Zentivafrom January 21st to February 4th. At the end of last year, the EU regulators said that the deal notification was incomplete and asked them to re-notify (Scrip Online, November 12th, 2008). Sanofi-Aventis might have proposed concessions such as the sale of affiliated companies to reduce its potential dominance in one or more countries after the merger. The board of the Czech Republic's largest manufacturer of generic drugs accepted Sanofi-Aventis's proposal to pay €1.8 billion for all ofits shares on September 22nd.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts